330712X

LIPIDOMIX^™ Mass Spec Standard

Avanti Research^™ - A Croda Brand

• 別名: LIPIDOMIX^™ Mass Spec Standard, solution (1:1 dichloromethane:methanol)
• UNSPSCコード: 41116107
• NACRES: NA.24

特性

• 形状: solution (1:1 dichloromethane:methanol)
• 包装: ampule of 1 × 1 mL (330712X-1EA)
• メーカー／製品名: Avanti Research^™ - A Croda Brand
• 輸送温度: dry ice
• 保管温度: −20°C

詳細

包装

2 mL amber glass sealed ampule

構成

The Ceramide LIPIDOMIX Mass Spec Standard is supplied in 1 mL of (1:1) dichloromethane:methanol and contains the following components:

Mixture ComponentTarget Conc. (μM)

• C16 Ceramide (d18:1/16:0)30
• C18 Ceramide (d18:1/18:0)15
• C24 Ceramide (d18:1/24:0)75
• C24:1 Ceramide (d18:1/24:1(15Z))37.5

法的情報

Avanti Research is a trademark of Avanti Polar Lipids, LLC

LIPIDOMIX is a trademark of Avanti Polar Lipids, LLC

キットの構成要素は別途購入可能です。

• 860516P C16 Ceramide (d18:1/16:0), Avanti Research^™ - A Croda Brand 16.1μg/mL
• 860518P C18 Ceramide (d18:1/18:0), Avanti Research^™ - A Croda Brand 8.5μg/mL
• 860524P C24 Ceramide (d18:1/24:0), Avanti Research^™ - A Croda Brand 48.8μg/mL
• 860525P C24:1 Ceramide (d18:1/24:1(15Z)), Avanti Research^™ - A Croda Brand 24.3μg/mL

安全性情報

• ピクトグラム: GHS02,GHS06,GHS08
• シグナルワード: Danger
• 危険有害性情報: H225,H301 + H311 + H331,H315,H319,H336,H351,H370
• 注意書き: P210 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311 - P305 + P351 + P338
• 危険有害性の分類: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Carc. 2 - Eye Irrit. 2 - Flam. Liq. 2 - Skin Irrit. 2 - STOT SE 1 - STOT SE 3
• ターゲットの組織: Central nervous system, Eyes,Central nervous system
• 保管分類コード: 3 - Flammable liquids
• WGK: WGK 2
• 引火点(°F): 49.5 °F
• 引火点(℃): 9.7 °C